Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T78932 | Target Info | |||
Target Name | TYK2 tyrosine kinase (TYK2) | ||||
Synonyms |
Non-receptor tyrosine-protein kinase TYK2
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | TYK2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Janus kinase 1 (JAK-1) | Successful Target | ||||
UniProt ID | JAK1_HUMAN | |||||
Gene Name | JAK1 | |||||
Synonyms |
Tyrosine-protein kinase JAK1; JAK1B; JAK1A
Click to Show/Hide
|
|||||
Representative Drug(s) | Deucravacitinib | Drug Info | IC50 = 1 nM | [1] | ||
Co-Target Name | Bone morphogenetic protein receptor (BMPR2) | Literature-reported Target | ||||
UniProt ID | BMPR2_HUMAN | |||||
Gene Name | BMPR2 | |||||
Synonyms |
PPH1; Bone morphogenetic protein receptor type-2; Bone morphogenetic protein receptor type II; BMPR-II; BMPR-2; BMP type-2 receptor; BMP type II receptor
Click to Show/Hide
|
|||||
Representative Drug(s) | Deucravacitinib | Drug Info | IC50 = 193 nM | [1] | ||
Co-Target Name | Tyrosine protein kinase JAK1-Tyrosine protein kinase JAK3 complex (JAK1-JAK3) | Co-Target | ||||
UniProt ID | JAK3_HUMAN-JAK1_HUMAN | |||||
Gene Name | JAK1-JAK3 | |||||
Representative Drug(s) | Deucravacitinib | Drug Info | IC50 = 592 nM | [1] | ||
Co-Target Name | Tyrosine protein kinase JAK1-Tyrosine protein kinase JAK2 complex (JAK1-JAK2) | Co-Target | ||||
UniProt ID | JAK1_HUMAN-JAK2_HUMAN | |||||
Gene Name | JAK2-JAK1 | |||||
Representative Drug(s) | Deucravacitinib | Drug Info | IC50 = 609 nM | [1] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165. J Med Chem. 2019 Oct 24;62(20):8973-8995. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.